• Zhejiang Taimei Medical Technology filed a next-day disclosure return reporting a repurchase of 70,000 H shares on July 20, 2026.
• Total repurchased shares: 70,000; none repurchased for cancellation.
• Buyback price range HKD 5.7–HKD 5.92; average HKD 5.81; aggregate consideration HKD 406,732.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhejiang Taimei Medical Technology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260720-12250087), on July 20, 2026, and is solely responsible for the information contained therein.